Organogenesis: 3Q Earnings Snapshot

November 12, 2019 GMT

CANTON, Mass. (AP) _ Organogenesis Holdings Inc. (ORGO) on Tuesday reported a loss of $10.7 million in its third quarter.

On a per-share basis, the Canton, Massachusetts-based company said it had a loss of 12 cents.

The regenerative medicine company posted revenue of $64.3 million in the period.

Organogenesis expects full-year revenue in the range of $253 million to $260 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ORGO at https://www.zacks.com/ap/ORGO